AGL 41.50 Increased By ▲ 2.96 (7.68%)
AIRLINK 128.00 Decreased By ▼ -1.50 (-1.16%)
BOP 6.26 Increased By ▲ 0.65 (11.59%)
CNERGY 4.13 Increased By ▲ 0.27 (6.99%)
DCL 8.44 Decreased By ▼ -0.29 (-3.32%)
DFML 40.69 Decreased By ▼ -1.07 (-2.56%)
DGKC 87.90 Decreased By ▼ -0.40 (-0.45%)
FCCL 34.10 Decreased By ▼ -0.90 (-2.57%)
FFBL 66.33 Decreased By ▼ -1.02 (-1.51%)
FFL 10.56 Decreased By ▼ -0.05 (-0.47%)
HUBC 108.70 Decreased By ▼ -0.06 (-0.06%)
HUMNL 14.46 Decreased By ▼ -0.20 (-1.36%)
KEL 4.65 Decreased By ▼ -0.10 (-2.11%)
KOSM 7.33 Increased By ▲ 0.38 (5.47%)
MLCF 42.72 Increased By ▲ 1.07 (2.57%)
NBP 60.84 Increased By ▲ 1.24 (2.08%)
OGDC 178.97 Decreased By ▼ -4.03 (-2.2%)
PAEL 25.70 Decreased By ▼ -0.55 (-2.1%)
PIBTL 6.06 Increased By ▲ 0.09 (1.51%)
PPL 146.15 Decreased By ▼ -0.55 (-0.37%)
PRL 24.91 Increased By ▲ 1.30 (5.51%)
PTC 16.14 Decreased By ▼ -0.42 (-2.54%)
SEARL 70.20 Increased By ▲ 1.90 (2.78%)
TELE 7.22 Decreased By ▼ -0.01 (-0.14%)
TOMCL 36.20 Increased By ▲ 0.25 (0.7%)
TPLP 7.84 Decreased By ▼ -0.01 (-0.13%)
TREET 15.59 Increased By ▲ 1.39 (9.79%)
TRG 50.36 Decreased By ▼ -0.09 (-0.18%)
UNITY 26.90 Increased By ▲ 0.15 (0.56%)
WTL 1.24 Increased By ▲ 0.03 (2.48%)
BR100 9,795 Decreased By -11.1 (-0.11%)
BR30 29,647 Decreased By -31.2 (-0.1%)
KSE100 92,021 Decreased By -282.9 (-0.31%)
KSE30 28,665 Decreased By -175.5 (-0.61%)

The 'Network for Consumer Protection' has rejected the proposal to constitute 'Drug Regulatory Authority' (DRA) for surveillance over sale, manufacturing and registration of spurious and substandard medicines in the country, saying that this would further deteriorate the situation and would privatise the 'pharmaceutical regulations'.
The Executive Co-ordinator of the 'Network', an Islamabad based advocacy group working in public health and consumer protection for the last 14 years, Ayaz Kiani, addressing a press conference here on Wednesday, said: "A detailed study of the draft of the proposed body shows that the new 'authority' is being devised on the lines that would result in further mess up in the terms of further price hike in the chaotic pharmaceutical sector."
He said that the framework of the proposed body invites more intervention from industry and less regulation from the state. Tauqir Mustafa, Pharmaceutical Co-ordinator of the group, was also present on the occasion. Kiani said that the civil society sees this new 'authority' as an eyewash and an attempt to divert the attention of the people from real health issues.
"There is nothing new in the proposed 'authority' and instead of providing any measures to improve regulations it seems to serve the interests of pharmaceutical industry at the cost of public," he added.
He observed that the government wants to register some activism in health sector in the context of Supreme Court's suo motu action on spurious drugs and the growing awareness among masses about the dismal picture in the pharma sector, and the DRA rhetoric provides enough space to trumpet the steps.
The Drug Control Organisation, which is being replaced by the proposed 'authority' could have been used effectively if the rules and provisions provided in the Drug Act 1976 were implemented in letter and spirit.
He said that a cursory survey of the draft available on the Ministry of Health website shows that it does not offer substantial changes in the existing situation on which the apex court has shown much concern.
The proposed law is flawed and does not fulfil the promises made to the court. "It appears that the changes are aimed at some convenient administrative reshuffling and will, at best, bring some superficial and cosmetic changes," he added.
Tariq Mustafa said that the government, through this 'authority' is deliberately loosening its grip on regulation and this crucial part, which can guarantee the quality of pharma products and services, is being given in the hands of industry, whom this 'authority' is supposed to control.
"The government steps to introduce a new regulatory authority," he said, "does not make sense when a good law--Drug Act 1976--is already there. What the Ministry of Health needs is to implement this Act, portions of which were never implemented, rather than making another parallel body."
He said that the health sector should not have been dealt with like telecom sector where the consumers' grievances are shown to be addressed through claims and farce hearings. In health, he added, the consumer interest should be given top priority. Given its importance, no room should be provided to powerful industry players to enhance their influence in decision making.

Copyright Business Recorder, 2006

Comments

Comments are closed.